IL42314A - Pharmaceutical composition containing a glycyrrehetinic acid derivative and an antacid for the treatment of gastritis - Google Patents

Pharmaceutical composition containing a glycyrrehetinic acid derivative and an antacid for the treatment of gastritis

Info

Publication number
IL42314A
IL42314A IL42314A IL4231473A IL42314A IL 42314 A IL42314 A IL 42314A IL 42314 A IL42314 A IL 42314A IL 4231473 A IL4231473 A IL 4231473A IL 42314 A IL42314 A IL 42314A
Authority
IL
Israel
Prior art keywords
antacid
pharmaceutical composition
acid
composition according
glycyrrhetinic acid
Prior art date
Application number
IL42314A
Other languages
English (en)
Other versions
IL42314A0 (en
Original Assignee
Biorex Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biorex Laboratories Ltd filed Critical Biorex Laboratories Ltd
Publication of IL42314A0 publication Critical patent/IL42314A0/xx
Publication of IL42314A publication Critical patent/IL42314A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL42314A 1972-12-18 1973-05-20 Pharmaceutical composition containing a glycyrrehetinic acid derivative and an antacid for the treatment of gastritis IL42314A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5835572A GB1401360A (en) 1972-12-18 1972-12-18 Pharmaceutical composition

Publications (2)

Publication Number Publication Date
IL42314A0 IL42314A0 (en) 1973-07-30
IL42314A true IL42314A (en) 1976-09-30

Family

ID=10481403

Family Applications (1)

Application Number Title Priority Date Filing Date
IL42314A IL42314A (en) 1972-12-18 1973-05-20 Pharmaceutical composition containing a glycyrrehetinic acid derivative and an antacid for the treatment of gastritis

Country Status (10)

Country Link
AU (1) AU476390B2 (fr)
BE (1) BE802701A (fr)
CA (1) CA1018457A (fr)
DE (1) DE2360889A1 (fr)
FR (1) FR2210400B1 (fr)
GB (1) GB1401360A (fr)
IE (1) IE38521B1 (fr)
IL (1) IL42314A (fr)
NL (1) NL7317237A (fr)
ZA (1) ZA732439B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8307096A1 (es) * 1981-06-01 1983-07-01 Orion Yhtymae Oy "un metodo para preparar tabletas a base de polvos de medicamento acidicos, inocuas para el esofago".
AU553789B2 (en) * 1982-06-30 1986-07-24 Biorex Laboratories Ltd. Glycyrrhetinic acid derivatives in cream compositions
GB2122893B (en) * 1982-06-30 1985-06-26 Biorex Laboratories Ltd Glycyrrhetinic acid compositions
US4861591A (en) * 1987-11-18 1989-08-29 American Home Products Corporation Formulations for hygroscopic pharmaceuticals

Also Published As

Publication number Publication date
DE2360889A1 (de) 1974-06-20
ZA732439B (en) 1974-03-27
BE802701A (fr) 1974-01-23
CA1018457A (fr) 1977-10-04
IL42314A0 (en) 1973-07-30
NL7317237A (fr) 1974-06-20
FR2210400A1 (fr) 1974-07-12
AU6312773A (en) 1975-06-05
IE38521B1 (en) 1978-03-29
IE38521L (en) 1974-06-18
GB1401360A (en) 1975-07-16
FR2210400B1 (fr) 1977-07-15
AU476390B2 (en) 1976-09-16

Similar Documents

Publication Publication Date Title
US3773946A (en) Triglyceride-lowering compositions and methods
ES8107207A1 (es) Procedimiento de preparacion de derivados de tiadiazol
SE7614258L (sv) Forfarande for framstellning av kinazoloderivat
ES475338A1 (es) Procedimiento para la obtencion de derivados o-sustituidos del (+)-cianidanol-3
US3944660A (en) Pharmaceutical composition
IL42314A (en) Pharmaceutical composition containing a glycyrrehetinic acid derivative and an antacid for the treatment of gastritis
EP0028336B1 (fr) Dérivé du O-phosphate de créatinol ayant une action thérapeutique et procédé pour sa préparation
IL65787A (en) Antiviral pharmaceutical compositions containing alpha,alpha-dialkyl-adamantylamines
US3787581A (en) Pharmaceutical compositions and methods of treatment
US3501577A (en) Method of treating hypertension with alkali metal salts of zinc diethylenetriaminepentaacetate
EP0340540B1 (fr) Agent pour la prophylaxie de l'infarctus du coeur et pour prévenir d'un autre infarctus
ES469804A1 (es) Procedimiento para la obtencion de nuevos compuestos de 6- amino-penam.
ES8305759A1 (es) "un procedimiento para la preparacion de 1-(1,3-bendodioxol-5-il)-2-pirrolidinona".
US3766168A (en) N6-(chlorobuten - 2 - yl)-adenosines and processes for the preparation thereof
US3887706A (en) N6-(3-Chlorobuten-2-yl)-adenosines as anti-inflammatory agents
GB1276589A (en) 0-alkyl-6-azauracil compounds and compositions containing the same
US2611732A (en) Compositions containing mixtures of 4-aminosalicylic acid and its basic calcium salt
GB1350929A (en) Pharmaceutical compositions
US2598004A (en) Stabilized tetrathiodilactic and tetathiodiglycollic acid pharmaceutical
GB1464082A (en) Pharmaceutical 'ompositions containing benzylamines
JPS6234038B2 (fr)
US3501576A (en) Method of treating hypertension with alkali metal salts of zinc trans - 1,2 - diaminocyclohexane-n,n,n',n'-tetraacetate
US3708579A (en) Anti-arthritic compositions comprising a trialkylphosphinegold complex of a 1-beta-d-glucopyranoside and methods of producing anti-arthritic activity
GB1217822A (en) Pharmaceutical compositions
US4093719A (en) Antiarthritic compositions comprising bis[(trialkyl-phosphine)gold(I)]sulfides and methods of producing antiarthritic activity